September 29, 2008 – Allscripts Healthcare Solutions and Misys plc issued a statement that they have sufficient funding commitments in place to finance its proposed purchase of shares of Allscripts common stock upon obtaining $325 million in financing for the merger.
Misys stated that it has signed definitive agreements for $325 million of financing to replace its credit facility with Lehman Brothers. Misys stated that it will use the new credit facilities to fund a portion of the consideration for the proposed purchase of shares of common stock of Allscripts.
According to Misys, the new financing will be provided by two sources: a $150 million revolving credit facility will be provided for a term of 18 months by a lending group comprising HSBC Bank plc, the Governor and Company of the Bank of Ireland, and The Royal Bank of Scotland plc; and the remaining $175 million financing will be provided by ValueAct Capital, Misys’s largest shareholder, under a subordinated credit facility for a term of 20 months.
Misys also confirmed in its press release that the $150 million of proceeds from Misys’ equity offering in March 2008, which was underwritten by ValueAct Capital, remains in place.
For more information: www.misys.com
March 14, 2024 
